Rates and predictors of serious infections in MS and NMOSD patients treated with anti-CD20 therapy

被引：0
|
作者：
Mears, V. [1 ]
Jakubecz, C. [1 ]
Serra, A. [1 ]
Abboud, H. [1 ]
机构：
[1] Univ Hosp Cleveland Med Ctr, Case Western Reserve Univ, Cleveland, OH USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2022年 / 28卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P331
引用
收藏
页码：357 / 357
页数：1
相关论文
共 50 条
  • [1] Rates and Predictors of Serious Infections in MS and NMOSD Patients treated with Anti-CD20 Therapy
    Abboud, Hesham
    Mears, Veronica
    Jakubecz, Collin
    Serra, Alessandro
    [J]. NEUROLOGY, 2023, 100 (17)
  • [2] Impact on innate immunity of anti-cd20 therapy for ms
    Corbisiero, Silvia
    Guerrera, Gisella
    D'Orso, Silvia
    Picozza, Mario
    Pirronello, Marta
    Verdiani, Alice
    Angelini, Daniela
    Tortorella, Carla
    Ruggieri, Serena
    Giulietti, Giovanni
    Gasperini, Claudio
    Borsellino, Giovanna
    Battistini, Luca
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 969 - 970
  • [3] Predictors of hypogammaglobulinemia and serious infections among patients receiving ocrelizumab or rituximab for treatment of MS and NMOSD
    Mears, Veronica
    Jakubecz, Collin
    Seeco, Catherine
    Woodson, Sophia
    Serra, Alessandro
    Abboud, Hesham
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2023, 377
  • [4] Anti-cd20 therapy interferes with the immune response to the hepatitis b virus vaccine in ms patients
    Otero-Romero, S.
    Cardenas-Robledo, S.
    Rodriguez, M.
    Uriona, S.
    Rando, A.
    Vidal-Jordana, A.
    Esperalba, J.
    Del Amo, E.
    Rodrigo-Pendas, J.
    Campins, M.
    Martinez, X.
    Tintore, M.
    Montalban, X.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 260 - 260
  • [5] Anti-CD20 therapy in rheumatoid arthritis
    Roll, P.
    Tony, H. -P.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2009, 68 (05): : 370 - +
  • [6] Resolved HBV and anti-CD20 therapy
    Hicks, Lisa K.
    Feld, Jordan J.
    [J]. BLOOD, 2019, 133 (02) : 104 - 106
  • [7] Longitudinal analysis of peripheral immune cells in patients with multiple sclerosis treated with anti-CD20 therapy
    Waede, Mie
    Voss, Lasse F.
    Kingo, Christina
    Moeller, Jesper B.
    Elkjaer, Maria L.
    Illes, Zsolt
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024,
  • [8] RISK OF HEPATITIS B INFECTION REACTIVATION IN RHEUMATIC DISEASES PATIENTS TREATED WITH ANTI-CD20 THERAPY
    Fornaro, M.
    Lopalco, G.
    Venerito, V.
    Barone, M.
    Cantarini, L.
    Fabiani, C.
    Emmi, G.
    Silvestri, E.
    Lapadula, G.
    Lannone, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 583 - 583
  • [9] HBV Care Map for Patients Receiving Anti-CD20 Therapy
    Liederman, Zachary
    Berinstein, Neil
    Crump, Michael
    Hwang, Jessica
    Janssen, Harry L. A.
    Kouroukis, C. Tom
    Leung, Patricia
    Lok, Anna
    Yim, Colina
    Zelenetz, Andrew D.
    Chan, Kelvin
    Feld, Jordan
    Hicks, Lisa K.
    [J]. BLOOD, 2017, 130
  • [10] Resistant Kawasaki Disease Treated with Anti-CD20
    Sauvaget, Emilie
    Bonello, Beatrice
    David, Marion
    Chabrol, Brigitte
    Dubus, Jean-Christophe
    Bosdure, Emmanuelle
    [J]. JOURNAL OF PEDIATRICS, 2012, 160 (05): : 875 - 876
12345